NCT07459543 2026-03-09
A Study To Assess the Safety, and Tolerability of Nivolumab + Relatlimab Fixed-Dose Combination (FDC) In Untreated, Unresectable or Metastatic Melanoma Participants In India
Bristol-Myers Squibb
Phase 4 Not yet recruiting
Clinical Trials
14 trialsNCT07455331 2026-03-06
LANCE
Jules Bordet Institute
Phase 2 Not yet recruiting
NCT07426484 2026-02-23
Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy
Dana-Farber Cancer Institute
Phase 4 Not yet recruiting
NCT07286318 2026-02-19
A Randomized Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients
University of Pittsburgh
Phase EARLY_PHASE1 Not yet recruiting
NCT07387198 2026-02-04
NeoMatryx
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Phase 2 Not yet recruiting
NCT07247123 2026-01-27
Developing and Testing the Effectiveness of a Skin Cancer Self-Detection Educational Program
National University Hospital, Singapore
Phase NA Not yet recruiting
NCT07349940 2026-01-20
MEL
Institute of Health Information and Statistics of the Czech Republic
Phase NA Not yet recruiting
NCT07330323 2026-01-09
CARES
Universitaire Ziekenhuizen KU Leuven
Phase NA Not yet recruiting
NCT06615635 2025-12-02
DaRT
Alpha Tau Medical LTD.
Phase NA Not yet recruiting
NCT07201012 2025-11-17
SMT-SL
Centre Hospitalier Universitaire de NÄ«mes
Phase NA Not yet recruiting
NCT07040280 2025-06-27
Testing the Effect of Sulforaphane, a Compound Naturally Found in Cruciferous Vegetables, on Preventing Melanoma in Patients With a Prior History of Melanoma
Eastern Cooperative Oncology Group
Phase 2 Not yet recruiting
NCT07040683 2025-06-27
LEGS
Region Skane
Phase NA Not yet recruiting
NCT06489301 2025-03-25
Mechanisms for Laser-Induced Rejuvenation
Wright State University
Phase NA Not yet recruiting
NCT04064424 2024-12-17
Cancer Prevention & Online Technologies
Stanford University
Phase NA Not yet recruiting